A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design-Reference-Cited by-同舟云学术

A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design

Published:2019-02-14 Issue:2 Volume:2 Page:e1161
ISSN:2573-8348
Container-title:CANCER REPORTS
language:en
Short-container-title:Cancer Reports

Author:

Goda Jayant S.¹^ORCID,Lewis Shirly C.¹,Laskar Siddartha¹,Kannan Sadhna²,Khanna Nehal¹,Jain Hasmukh³,Bagal Bhausaheb³,Epari Sridhar

Affiliation:

1. Department of Radiation Oncology, Tata Memorial CentreHomi Bhaba National Institute Mumbai India

2. Department of Epidemiology and Clinical Trials Unit, ACTREC, Tata Memorial CentreHomi Bhaba National Institute Navi Mumbai India

3. Department of Hemato Oncology, Tata Memorial HospitalHomi Bhaba National Institute Mumbai India

Funder

Science and Engineering Research Board

Department of Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1161

Reference21 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

3. Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

4. Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

5. Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736